Latest News
-
IONTAS announces new antibody optimisation agreement with Teva PharmaceuticalsUnder the terms of the agreement, IONTAS will initially apply its proprietary technologies to provide Teva with a panel of optimised antibodies against a defined target.Read More
-
IONTAS publish discovery and optimisation research article showing the utility of mammalian display in antibody discovery.A comprehensive search of functional sequence space using large mammalian display libraries created by gene editingRead More
-
IONTAS R&D activities approved for French Research Tax Credit statusThe available tax credits will apply to antibody discovery programs using both phage display and mammalian display, allowing French companies to receive significant reimbursement from the French government when accessing IONTAS’s premium services.Read More
Events
-
BIO Europe 201911-13 November 2019
Hamburg Messe
GermanyRead More -
PEGS Summit Europe 201918-22 November 2019
Lisbon Congress Center
Lisbon, PortugalRead More -
Antibody Engineering and Therapeutics 201909-13 December 2019
Marriott Marquis
San DiegoRead More -
J.P Morgan Healthcare Conference13-17 January 2020
San Francisco
CaliforniaRead More -
PEGS Boston 202004-08 May 2020
Seaport hotel
Boston, Massachusetts, United StatesRead More